Table 3 Correlations between PD-L1 Tumor Proportion Score with oncogenic driver mutation status in 196 non-squamous carcinoma cases

From: Programmed death ligand-1 expression in non-small cell lung cancer in a Western Australian population and correlation with clinicopathologic features

 

No. of cases n = 196

PD-L1 < 1% n = 61 (31%)

PD-L1 1–49% n = 73 (37%)

PD-L1 ≥ 50% n = 62 (32%)

p-value

 

N (%)

EGFR mutation

25 (13)

11 (44)

7 (28)

7 (28)

0.69

RAS mutation

68 (35)

18 (26)

27 (40)

23 (34)

 

ALK translocation

4 (2)

2 (50)

1 (25)

1 (25)

 

ROS1 translocation

3 (2)

0 (0)

1 (33)

2 (67)

 

Pan-wildtype

96 (49)

30 (31)

37 (39)

29 (30)